Insights Blog

In January of each year CLSI publishes M100—Performance Standards for Antimicrobial Susceptibility Testing. M100 reports the antibiotic breakpoints that help medical laboratorians throughout the world provide accurate test results to health care providers. These breakpoints aid laboratorians in selecting the most appropriate and effective antimicrobial treatments for patients.

Presented by CLSI, read the article, “The Antibiotic Resistance Laboratory Network (AR Lab Network) – Bridging the Gap by Offering Expanded Antimicrobial Susceptibility Testing,” byPaula Snippes Vagnone, AR Lab Network Central Region Lab Coordinator, Minnesota Department of Health, Public Health Laboratory, St. Paul, MN.

CLSI publishes rationale documents that provide the scientific reasons behind the decisions related to breakpoint and interpretive categories. Learn more.

The CDC is reporting that Candida auris, an emerging fungus, presents a serious global health threat, causing severe illness in hospitalized patients.

CLSI raises awareness of Clostridium difficile infections this November. Clostridium difficile infections in the community appear to be rising. Learn more.

The importance of Viral Load Testing in treating HIV and how it can help countries meet their UN AIDS 90-90-90 initiative targets. Find out more at CLSI.

AIME, a start up company, has developed a new software that can accurately predict the spread of Dengue three months ahead of an outbreak.

A forgotten antibiotic has shown promise in treating antimicrobial resistant bacteria.

Find the answer to "When Should Clinical Microbiology Laboratories Perform Carbapenemase Detection Tests?"

This article features a case study on the direct detection of MRSA/MSSA from positive blood cultures.